EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · IEX Real-Time Price · USD
20.67
-0.14 (-0.67%)
At close: Mar 28, 2024, 4:00 PM
20.26
-0.41 (-1.98%)
After-hours: Mar 28, 2024, 7:00 PM EDT

EyePoint Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2003
Cash & Equivalents
281.4195.78178.7445.0622.3638.9317.0515.4619.2715.48
Upgrade
Short-Term Investments
49.7948.9332.97000013.689.412.94
Upgrade
Cash & Cash Equivalents
331.2144.71211.7145.0622.3638.9317.0529.1428.6918.43
Upgrade
Cash Growth
128.87%-31.65%369.85%101.48%-42.55%128.33%-41.50%1.59%55.66%79.38%
Upgrade
Receivables
0.8115.518.359.4511.370.350.250.490.620.52
Upgrade
Inventory
3.912.893.625.342.1400000
Upgrade
Other Current Assets
8.899.714.073.275.850.630.440.330.530.4
Upgrade
Total Current Assets
344.8172.81237.7563.1241.7239.9117.7429.9629.8419.34
Upgrade
Property, Plant & Equipment
10.237.42.733.243.440.250.310.290.340.3
Upgrade
Goodwill and Intangibles
0022.7525.2127.6731.360.361.11.932.77
Upgrade
Other Long-Term Assets
0.150.150.150.150.150.150.260.260.270.27
Upgrade
Total Long-Term Assets
10.387.5525.6328.631.2531.760.941.662.533.33
Upgrade
Total Assets
355.18180.36263.3791.7272.9771.6718.6831.6232.3722.67
Upgrade
Accounts Payable
6.55.927.394.814.192.941.021.360.740.46
Upgrade
Deferred Revenue
59.2814.7615.6316.560.0200.055.735.635.72
Upgrade
Current Debt
010.4800000000
Upgrade
Other Current Liabilities
-2.533.380.64-6.487.3118.724.22-2-3.03-4.06
Upgrade
Total Current Liabilities
63.2634.5423.6614.8911.5221.665.295.093.352.13
Upgrade
Long-Term Debt
4.9135.2938.4240.3150.1217.310000
Upgrade
Other Long-Term Liabilities
20.6914.1616.9117.98321.010.055.655.655.62
Upgrade
Total Long-Term Liabilities
25.649.4555.3358.2953.1238.320.055.655.655.62
Upgrade
Total Liabilities
88.8683.9978.9973.1864.6459.985.3410.7497.75
Upgrade
Total Debt
4.9145.7738.4240.3150.1217.310000
Upgrade
Debt Growth
-89.28%19.12%-4.68%-19.58%189.57%-----
Upgrade
Retained Earnings
-742.15-671.35-569.1-510.68-465.29-363.99-310.82-292.21-270.67-277.01
Upgrade
Comprehensive Income
0.860.790.840.840.840.840.830.850.951.04
Upgrade
Shareholders' Equity
266.3296.37184.3818.548.3311.6913.3420.8823.3714.92
Upgrade
Net Cash / Debt
326.2998.94173.294.75-27.7621.6217.0529.1428.6918.43
Upgrade
Net Cash / Debt Growth
229.78%-42.90%3546.59%--26.80%-41.50%1.59%55.66%79.38%
Upgrade
Net Cash Per Share
8.392.656.030.37-2.664.684.829.229.386.71
Upgrade
Working Capital
281.54138.27214.0948.2330.218.2512.4524.8726.4917.22
Upgrade
Book Value Per Share
6.852.586.411.440.802.533.776.607.955.44
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).